Amicus Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Revenue Growth Guidance.
Amicus Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Revenue Growth Guidance.
愛美醫療股價上漲，公司公佈了超出預期的Q3財務業績，並提高了FY24營業收入增長預期。
Amicus Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Revenue Growth Guidance.
愛美醫療股價上漲，因公司公佈了優於預期的第三季度財務業績，並提高了2024財年營業收入增長預期。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間